Patient Recruitment & Enrollment Services for Researchers

Accelerate clinical trials with cost-effective recruitment and enrollment campaigns powered by MyGi Health patient population.

Recruitment & Enrollment

Leveraging proprietary algorithms and analytics tools, we build “Custom Audiences” to pinpoint well-characterized and highly motivated clinical trial candidates, reducing direct-to-consumer and other expensive marketing costs related to trial enrollment and unbranded campaigns. Additionally, our customized patient portals and digital scheduling tools simplify the patient and trial coordination experience for sponsors and CROs.

  • Geo-Targeting: Create localized digital campaigns for each clinical trial site
  • Digital Funnel: Utilize digital tools to create customized landing pages and screeners
  • Custom Tools: Deploy proprietary tools to quickly and efficiently find patients that meet trial criteria
  • Campaign Optimization: Provide oversight, generate and analyze reporting, and improve campaign performance

Powered by MyGi Health, a homebase for the 70 million+ sufferers of GI disorders in the U.S.

Sample Clinical Studies and Posters

Prevalence and Burden of Illness of Rome IV Irritable Bowel Syndrome in the U.S

Christopher V. Almario, MD, MSHPM, Cedars-Sinai Medical Center, Los Angeles, CA; William D. Chey, MD, Michigan Medicine, Ann Arbor, MI; Carolyn S. Higgins, MS, MBA, Ironwood Pharmaceutical, Cambridge, MA; Brennan M.R. Spiegel, MD, MSHS, Cedars-Sinai Medical Center, Los Angeles, CA
VIEW STUDY

Prevalence of Bowel Disorders in Multiple Sclerosis and Parkinson’s Disease: Results from a Nationwide Survey of Nearly 90,000 Americans

Christopher V. Almario, MD, MSHPM, Cedars-Sinai Medical Center, Los Angeles, CA; William D. Chey, MD, Michigan Medicine, Ann Arbor, MI; Carolyn S. Higgins, MS, MBA, Ironwood Pharmaceutical, Cambridge, MA; Brennan M.R. Spiegel, MD, MSHS, Cedars-Sinai Medical Center, Los Angeles, CA
VIEW STUDY

Prevalence of and Factors Associated with Fecal Incontinence—Results from a Population-based survey

Menees SB, Almario CV, Spiegel BMR, Chey WD. Prevalence of and Factors Associated With Fecal Incontinence: Results From a Population-Based Survey. Gastroenterology. 2018 May;154(6):1672-1681.e3. doi: 10.1053/j.gastro.2018.01.062. Epub 2018 Feb 3. PMID: 29408460; PMCID: PMC6370291.
VIEW STUDY

Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor—Refractory Symptoms

Delshad SD, Almario CV, Chey WD, Spiegel BMR. Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms. Gastroenterology. 2020 Apr;158(5):1250-1261.e2. doi: 10.1053/j.gastro.2019.12.014. Epub 2019 Dec 19. PMID: 31866243; PMCID: PMC7103516.
VIEW STUDY

Sample Research Partners

News & Insights

Ready to get started?

Contact our team to review your research project details!
CONTACT US